Brian McKelligon, President and CEO at Akoya Biosciences, Inc. (AKYA), sold 7,500 shares at $4.25 ($32K) on 2023-12-12, disclosed to the SEC on 2023-12-14.
Scheduled sale ($32k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AKYA | SELL | 2024-03-22 | $37K | — | Filing → |
| AKYA | SELL | 2024-03-22 | $37K | — | Filing → |
| AKYA | SELL | 2023-12-20 | $34K | — | Filing → |